Trial reportBMC oral health2026
Effects of albumin-platelet-rich fibrin as an adjunct to non-surgical periodontal therapy in patients with periodontitis: a randomized controlled clinical trial.
Trial report in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07363135 (Evaluation of Albumin Platelet-Rich Fibrin Application Following Scaling and Root Planing on Gingival Crevicular Fluid Growth Factors in Patients With Periodontitis), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of Albumin Platelet-Rich Fibrin Application Following Scaling and Root Planing on Gingival Crevicular Fluid Growth Factors in Patients With Periodontitis
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAlthough platelet-rich fibrin (PRF) is a biological material with high regenerative potential, its rapid resorption limits its clinical effectiveness. Albumin-platelet-rich fibrin (Alb-PRF), developed in recent years, exhibits prolonged resorption time. The aim of this study was to evaluate the clinical, radiographic, and biochemical effects of Alb-PRF application into periodontal pockets following non-surgical periodontal therapy (NSPT) using a randomized split-mouth design.
methodsThis study included 23 patients diagnosed with Stage III Grade B periodontitis. Following completion of NSPT, Alb-PRF was applied into periodontal pockets at the test sites. Gingival crevicular fluid (GCF) samples were collected on days 7, 14, and 21. Clinical periodontal parameters were recorded at baseline, 3 and 6 months, and radiographs were obtained at baseline and at 6 months. Levels of vascular endothelial growth factor (VEGF), platelet-derived growth factor-BB (PDGF-BB), transforming growth factor-β (TGF-β), and basic fibroblast growth factor (b-FGF) in GCF were analyzed using enzyme-linked immunosorbent assay (ELISA). Primary outcome measures included changes in probing depth (PD), clinical attachment loss (CAL), and GCF growth factor levels, while secondary outcome measures included changes in plaque index, gingival index (GI), bleeding on probing, gingival recession, and radiographic parameters.
resultsGI, PD, and CAL were significantly lower at test sites at 3 months (p < 0.01). However, these differences were not maintained at the 6-month follow-up. Radiographic defect depth and bone loss percentage were significantly lower at test sites at 6 months (p < 0.01). Transforming growth factor-β values were significantly higher at test sites at all subsequent time points (p < 0.01, p < 0.01, and p < 0.05, respectively).
conclusionsAlb-PRF may represent a beneficial adjunctive approach for early periodontal healing following NSPT; however, further studies are needed to clarify the sustainability of these effects over time.
trial registrationClinicalTrials.gov NCT07363135, registered on 15 January 2026 (retrospectively registered).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.